Our leadership team, including recognized physician experts and researchers, is at the forefront of shaping new standards of cancer care based upon the latest research. Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, providing patients with cutting-edge treatments and upholding the highest quality care for patients from diagnosis through survivorship.
Kent Shih, MD
Senior Investigator, Neuro-Oncology Program; Principal Investigator
Dr. Shih joined Sarah Cannon in 2010 and serves as senior investigator of the neuro-oncology program. In this role he serves as principal investigator in numerous neuro-oncology trials, conducts a brain tumor clinic including a drug development CNS clinic and serves as part of a multi-disciplinary neuro-oncology team.
Shih completed medical school and residency in internal medicine at Vanderbilt University in 2000. He then completed his fellowship in medical oncology at Johns Hopkins University School of Medicine in 2003. Shih specializes in all adult malignancies and holds memberships in the American Society of Clinical Oncology, the American Association for Cancer Research and Society of Neuro-Oncology. Additionally, he is an associate with Tennessee Oncology, PLLC.